Stanford researchers in the Xing Lab have developed GPT-RadPlan, a large language model (LLM) and vision-language model (VLM) based radiation therapy treatment planning automation tool that reduces treatment planning time and lowers costs.
Stanford researchers at the Ferrara Lab have developed a method to select receptor targets for molecular imaging and therapies by applying spatial transcriptomics, proteomics, and machine learning.
Stanford researchers at the Ferrara Lab have designed an ultra-fast standing device for breast ultrasound which is more comfortable than current designs and has higher resolution.
Stanford researchers have invented a unified AI architecture that integrates foundational models (FMs) with AI techniques for efficient analysis of fMRI data in psychiatric disorders.
Stanford researchers in the Khosla lab have invented a new class of "molecular glues" that couple the enzymatic activity of a cell-surface enzyme, transglutaminase 2 (TG2), with the ability of the LDL receptor-related protein 1 (LRP-1) to promote receptor-mediated endocytosis
Stanford inventors have developed an early-stage screening method to diagnose abdominal aortic aneurysms (AAA). AAA is a common cardiovascular disease with high prevalence in European men 65 years and above.
Active manipulation of light beams is required for a range of emerging optical technologies, including sensing, optical computing, virtual/augmented reality, dynamic holography, and computational imaging.
Researchers in Prof. Karl Deisseroth's laboratory have patented a revolutionary technique that can be utilized to map neural circuits in the whole brain.
Stanford scientists developed a novel strategy that uses resting-state functional connectivity magnetic resonance imaging (rs-fMRI) to determine whether a person will respond to treatment for depression.
Stanford inventors have created a novel, interactive, highly scalable computational approach for representing dynamic brain activity as a network for use in clinical settings.
Stanford researchers from the Khuri-Yakub group have designed an improved, high spatial resolution ultrasonic neuromodulation device that implements chip waveform instead of continuous wave PIRF.